Celltrion says its COVID-19 antibody shows ‘strong neutralising activity’ against Delta variant
20th July 2021 Uncategorised 0A therapeutic dose of regdanvimab also reduced the viral load of the SARS-CoV-2 virus and inflammation in the lungs
More: Celltrion says its COVID-19 antibody shows ‘strong neutralising activity’ against Delta variant
Source: News